id	sid	tid	token	lemma	pos
work_zzm6mmz64bct5j5jvndfx3hsdq	1	1	the	the	DT
work_zzm6mmz64bct5j5jvndfx3hsdq	1	2	distillery	distillery	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	3	SciBX	scibx	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	4	:	:	:
work_zzm6mmz64bct5j5jvndfx3hsdq	1	5	Science	Science	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	6	–	–	:
work_zzm6mmz64bct5j5jvndfx3hsdq	1	7	Business	Business	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	8	eXchange	eXchange	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	9	Copyright	Copyright	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	10	©	©	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	11	2008	2008	CD
work_zzm6mmz64bct5j5jvndfx3hsdq	1	12	Nature	Nature	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	13	Publishing	Publishing	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	14	Group	Group	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	15	�	�	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	16	This	this	DT
work_zzm6mmz64bct5j5jvndfx3hsdq	1	17	week	week	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	18	in	in	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	19	techniques	technique	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	1	20	Approach	Approach	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	21	Summary	Summary	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	22	Licensing	licensing	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	23	status	status	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	24	Publication	publication	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	25	and	and	CC
work_zzm6mmz64bct5j5jvndfx3hsdq	1	26	contact	contact	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	27	information	information	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	28	Disease	Disease	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	29	models	model	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	1	30	Rat	rat	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	31	model	model	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	32	for	for	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	33	identifying	identify	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	1	34	and	and	CC
work_zzm6mmz64bct5j5jvndfx3hsdq	1	35	characterizing	characterize	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	1	36	pain	pain	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	37	therapeutics	therapeutic	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	1	38	A	a	DT
work_zzm6mmz64bct5j5jvndfx3hsdq	1	39	rat	rat	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	40	model	model	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	41	of	of	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	42	inflammatory	inflammatory	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	1	43	pain	pain	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	44	may	may	MD
work_zzm6mmz64bct5j5jvndfx3hsdq	1	45	be	be	VB
work_zzm6mmz64bct5j5jvndfx3hsdq	1	46	useful	useful	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	1	47	for	for	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	48	identifying	identify	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	1	49	compounds	compound	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	1	50	that	that	WDT
work_zzm6mmz64bct5j5jvndfx3hsdq	1	51	treat	treat	VBP
work_zzm6mmz64bct5j5jvndfx3hsdq	1	52	chronic	chronic	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	1	53	peripheral	peripheral	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	1	54	pain	pain	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	55	without	without	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	56	inducing	induce	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	1	57	long-	long-	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	1	58	term	term	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	59	tolerance	tolerance	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	1	60	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	2	1	In	in	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	2	addition	addition	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	3	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	2	4	the	the	DT
work_zzm6mmz64bct5j5jvndfx3hsdq	2	5	model	model	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	6	should	should	MD
work_zzm6mmz64bct5j5jvndfx3hsdq	2	7	reduce	reduce	VB
work_zzm6mmz64bct5j5jvndfx3hsdq	2	8	discrepancies	discrepancy	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	2	9	between	between	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	10	models	model	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	2	11	of	of	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	12	tolerance	tolerance	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	13	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	2	14	which	which	WDT
work_zzm6mmz64bct5j5jvndfx3hsdq	2	15	previously	previously	RB
work_zzm6mmz64bct5j5jvndfx3hsdq	2	16	did	do	VBD
work_zzm6mmz64bct5j5jvndfx3hsdq	2	17	not	not	RB
work_zzm6mmz64bct5j5jvndfx3hsdq	2	18	include	include	VB
work_zzm6mmz64bct5j5jvndfx3hsdq	2	19	inflammatory	inflammatory	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	2	20	pain	pain	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	21	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	2	22	and	and	CC
work_zzm6mmz64bct5j5jvndfx3hsdq	2	23	clinical	clinical	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	2	24	studies	study	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	2	25	of	of	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	26	pain	pain	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	27	and	and	CC
work_zzm6mmz64bct5j5jvndfx3hsdq	2	28	tolerance	tolerance	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	2	29	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	3	1	In	in	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	2	rats	rat	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	3	3	with	with	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	4	complete	complete	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	3	5	Freund	Freund	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	3	6	’s	’s	POS
work_zzm6mmz64bct5j5jvndfx3hsdq	3	7	adjuvant	adjuvant	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	8	–	–	:
work_zzm6mmz64bct5j5jvndfx3hsdq	3	9	induced	induce	VBN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	10	hind	hind	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	3	11	-	-	HYPH
work_zzm6mmz64bct5j5jvndfx3hsdq	3	12	paw	paw	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	13	inflammation	inflammation	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	14	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	3	15	endogenous	endogenous	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	3	16	opioids	opioid	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	3	17	from	from	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	18	inflamed	inflamed	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	3	19	tissue	tissue	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	20	preserved	preserve	VBN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	21	µ-opioid	µ-opioid	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	22	receptor	receptor	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	23	signaling	signal	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	3	24	in	in	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	25	sensory	sensory	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	3	26	neurons	neuron	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	3	27	and	and	CC
work_zzm6mmz64bct5j5jvndfx3hsdq	3	28	consequently	consequently	RB
work_zzm6mmz64bct5j5jvndfx3hsdq	3	29	prevented	prevent	VBN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	30	peripheral	peripheral	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	3	31	opioid	opioid	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	3	32	tolerance	tolerance	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	3	33	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	4	1	Next	next	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	4	2	steps	step	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	4	3	include	include	VBP
work_zzm6mmz64bct5j5jvndfx3hsdq	4	4	studying	study	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	4	5	the	the	DT
work_zzm6mmz64bct5j5jvndfx3hsdq	4	6	mechanism	mechanism	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	4	7	of	of	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	4	8	µ-	µ-	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	4	9	opioid	opioid	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	4	10	receptor	receptor	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	4	11	signaling	signal	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	4	12	in	in	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	4	13	the	the	DT
work_zzm6mmz64bct5j5jvndfx3hsdq	4	14	rat	rat	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	4	15	model	model	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	4	16	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	5	1	No	no	RB
work_zzm6mmz64bct5j5jvndfx3hsdq	5	2	fewer	few	JJR
work_zzm6mmz64bct5j5jvndfx3hsdq	5	3	than	than	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	5	4	11	11	CD
work_zzm6mmz64bct5j5jvndfx3hsdq	5	5	companies	company	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	5	6	market	market	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	5	7	µ-opioid	µ-opioid	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	5	8	receptor	receptor	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	5	9	agonists	agonist	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	5	10	for	for	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	5	11	multiple	multiple	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	5	12	pain	pain	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	5	13	indications	indication	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	5	14	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	6	1	Rat	rat	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	6	2	model	model	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	6	3	is	be	VBZ
work_zzm6mmz64bct5j5jvndfx3hsdq	6	4	patented	patent	VBN
work_zzm6mmz64bct5j5jvndfx3hsdq	6	5	;	;	:
work_zzm6mmz64bct5j5jvndfx3hsdq	6	6	licensing	license	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	6	7	status	status	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	6	8	unknown	unknown	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	6	9	Zöllner	Zöllner	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	6	10	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	6	11	C.	C.	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	6	12	et	et	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	6	13	al	al	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	6	14	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	7	1	J.	J.	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	7	2	Clin	Clin	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	7	3	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	8	1	Invest	invest	VB
work_zzm6mmz64bct5j5jvndfx3hsdq	8	2	.	.	.
work_zzm6mmz64bct5j5jvndfx3hsdq	9	1	;	;	:
work_zzm6mmz64bct5j5jvndfx3hsdq	9	2	published	publish	VBN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	3	online	online	RB
work_zzm6mmz64bct5j5jvndfx3hsdq	9	4	Feb.	February	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	5	1	1	CD
work_zzm6mmz64bct5j5jvndfx3hsdq	9	6	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	9	7	2008	2008	CD
work_zzm6mmz64bct5j5jvndfx3hsdq	9	8	;	;	:
work_zzm6mmz64bct5j5jvndfx3hsdq	9	9	doi:10.1172	doi:10.1172	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	10	/	/	SYM
work_zzm6mmz64bct5j5jvndfx3hsdq	9	11	JCI25911	JCI25911	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	12	Contact	Contact	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	13	:	:	:
work_zzm6mmz64bct5j5jvndfx3hsdq	9	14	Christian	Christian	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	15	Zöllner	Zöllner	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	16	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	9	17	Charité	Charité	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	18	-	-	HYPH
work_zzm6mmz64bct5j5jvndfx3hsdq	9	19	Universitätsmedizin	Universitätsmedizin	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	20	Berlin	Berlin	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	21	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	9	22	Campus	Campus	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	23	Benjamin	Benjamin	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	24	Franklin	Franklin	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	25	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	9	26	Berlin	Berlin	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	27	,	,	,
work_zzm6mmz64bct5j5jvndfx3hsdq	9	28	Germany	Germany	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	29	e	e	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	30	-	-	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	31	mail	mail	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	32	:	:	:
work_zzm6mmz64bct5j5jvndfx3hsdq	9	33	christian.zoellner@charite.de	christian.zoellner@charite.de	JJ
work_zzm6mmz64bct5j5jvndfx3hsdq	9	34	http://www.scibx.com	http://www.scibx.com	ADD
work_zzm6mmz64bct5j5jvndfx3hsdq	9	35	mailto:christian.zoellner@charite.de	mailto:christian.zoellner@charite.de	NNP
work_zzm6mmz64bct5j5jvndfx3hsdq	9	36	Rat	rat	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	37	model	model	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	38	for	for	IN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	39	identifying	identify	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	9	40	and	and	CC
work_zzm6mmz64bct5j5jvndfx3hsdq	9	41	characterizing	characterize	VBG
work_zzm6mmz64bct5j5jvndfx3hsdq	9	42	pain	pain	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	43	therapeutics	therapeutic	NNS
work_zzm6mmz64bct5j5jvndfx3hsdq	9	44	Summary	summary	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	45	Licensing	licensing	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	46	status	status	NN
work_zzm6mmz64bct5j5jvndfx3hsdq	9	47	References	reference	NNS